Sleep Pharmaceuticals Archives - RTSleepWorld

November 29, 2023

xyrem xywav jazz pharmaceuticals

Jazz Pharmaceuticals Presents Latest Advancements at World Sleep 2023

October 18, 2023 RTSleepWorld

wakix pitolisant

Promising Results for Pitolisant in Prader-Willi Syndrome

October 10, 2023 RTSleepWorld

Sleep Pharmaceuticals

Jazz Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023

September 12, 2023 RTSleepWorld

Promising Results for Narcolepsy Type 1 Treatment, but Safety Concerns Arise

July 28, 2023 RTSleepWorld

Sleep Pharmaceuticals

Avadel Pharmaceuticals Receives FDA Approval of Bedtime Narcolepsy Treatment

May 2, 2023 RTSleepWorld

News

ApniMed Secures $80 Million for Apnea Pill Phase 3 Trials

January 3, 2023 RTSleepWorld

medications effect on sleep

Apnimed OSA Pill Completes Positive Phase 2 Clinical Trials

October 17, 2022 RTSleepWorld

Sleep Pharmaceuticals

Eisai to Present New Data On Lemborexant at SLEEP 2022

June 3, 2022 RTSleepWorld

Sleep Pharmaceuticals

Jazz to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine

June 3, 2022 RTSleepWorld

Sleep Pharmaceuticals

Idorsia Receives FDA Approval of QUVIVIQ for Insomnia

January 14, 2022 RTSleepWorld

©2010 - 2023 RTSleepWorld.com™, a BreakAway Media Group, LLC property.